- 专利标题: PYRROLIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BETA-AMYLOID OR TAU PROTEIN-ASSOCIATED DISEASES CONTAINING SAME
-
申请号: EP20906363.5申请日: 2020-12-22
-
公开(公告)号: EP4083037A1公开(公告)日: 2022-11-02
- 发明人: KIM, Youngsoo , SHIN, Jisu , HONG, Ki Bum , YU, Ji Hoon , LEE, Ji Hoon , KIM, Da Rong , JEON, Hui-Jeon , SONG, Jaeyoung , PARK, Jin Wan , LEE, Ju Suk , LEE, Won Seok , KIM, Young-Kyu , KIM, Sung Hwan , YOON, Heeseok
- 申请人: Yonsei University, University-Industry Foundation(UIF). , Daegu-Gyeongbuk Medical Innovation Foundation
- 申请人地址: KR Seoul 03722 50, Yonsei-ro Seodaemun-gu; KR Daegu 41061 88, Dongnae-ro Dong-gu
- 代理机构: Schön, Christoph
- 优先权: KR20190175321 20191226
- 国际公布: WO2021133037 20210701
- 主分类号: C07D417/06
- IPC分类号: C07D417/06 ; A61K31/427 ; A61K31/437 ; A61K31/4178 ; C07D277/36 ; C07D401/06 ; C07D405/06 ; C07D409/06 ; C07D471/04 ; A61P25/28
摘要:
Provided are: a novel pyrrolidine derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing same and having the effects of inhibiting beta-amyloid and/or tau protein aggregation, and/or breaking down beta-amyloid and/or tau protein aggregates, and/or preventing and/or treating beta-amyloid and/or tau protein-associated diseases.
信息查询